With delayed Release Solid Pharmaceutical formulation comprising emodepside and praziquantel

摘要

Claim 1: with delayed Release Solid Pharmaceutical preparation, comprising: a) at least a pharmaceutically Active Ingredient, (b) polyvinylpyrrolidone and / or a Derivative of polyvinylpyrrolidone with a value of K at least 17, c) at least one load.Claim 5: pharmaceutical Solid Preparation according to any of the preceding Claims, comprising a depsipeptide. Claim 2: Solid Pharmaceutical Preparation according to claim 5, comprising emodepside. Solid Pharmaceutical Preparation claim 7: According to claim 3, comprising emodepside and praziquantel.Claim 1: Solid Pharmaceutical Preparation according to any one of claims 1 to 4, which includes a Painkiller. Solid Pharmaceutical Preparation claim 9: According to claim 8, comprising dipyrone. Claim 1: Solid Pharmaceutical Preparation according to any one of claims 1 to 7, which comprises a macrocyclic lactone.Claim 1: Solid Pharmaceutical Preparation according to claim 10, comprising ivermectin. Claim 2: Solid Pharmaceutical Preparation according to any one of claims 1 to 4, comprising a phosphonic acid derivative of pharmacologically acceptable.Claim 1: Solid Pharmaceutical Preparation according to claim 12, which includes Butafosfano.